Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease

Journal of Biomedicine and Biotechnology

Volumn 2006, Issue , 2006, Pages

  Keller, Jeffrey N ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR;

ALZHEIMER DISEASE; CELL VIABILITY; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE ACTIVITY; DISEASE COURSE; HOMEOSTASIS; HUMAN; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REVIEW; STEADY STATE;

EID: 33646058269     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/JBB/2006/12129     Document Type: Review

References (20)

1. W R Markesbery Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiology of Aging 18 1997 4 suppl S13 S19
2. H M Wisniewski W Silverman Diagnostic criteria for the neuropathological assessment of Alzheimer's disease: current status and major issues. Neurobiology of Aging 18 1997 4 suppl S43 S50
3. J C Morris Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics 60 2005 6 suppl 9 14
4. R C Petersen R Doody A Kurz Current concepts in mild cognitive impairment. Archives of Neurology 58 2001 12 1985 1992
5. J N Keller F A Schmitt S W Scheff Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 64 2005 7 1152 1156
6. L M Sayre M A Smith G Perry Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Current Medicinal Chemistry 8 2001 7 721 738
7. M J Picklo T J Montine V Amarnath Carbonyl toxicology and Alzheimer's disease. Toxicology and Applied Pharmacology 184 2002 3 187 197
8. Q Ding W R Markesbery Q Chen Ribosome dysfunction is an early event in Alzheimer's disease. Journal of Neuroscience 25 2005 40 9171 9175
9. W R Markesbery R J Kryscio M A Lovell Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Annals of Neurology 58 2005 5 730 735
10. J Wang S Xiong C Xie Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. Journal of Neurochemistry 93 2005 4 953 962
11. B I Giasson H Ischiropoulos V M Lee J Q Trojanowski The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radical Biology and Medicine 32 2002 12 1264 1275
12. P Jenner C W Olanow Understanding cell death in Parkinson's disease. Annals of Neurology 44 1998 3 suppl 1 S72 S84
13. R S Sohal Role of oxidative stress and protein oxidation in the aging process. Free Radical Biology and Medicine 33 2002 1 37 44
14. B A Bahr J Bendiske The neuropathogenic contributions of lysosomal dysfunction. Journal of Neurochemistry 83 2002 3 481 489
15. T Grune K Merker G Sandig Selective degradation of oxidatively modified protein substrates by the proteasome. Biochemical and Biophysical Research Communications 305 2003 3 709 718
16. N S Langstrom J P Anderson H G Lindroos Alzheimer's disease-associated reduction of polysomal mRNA translation. Molecular Brain Research 5 1989 4 259 269
17. K Honda M A Smith X Zhu Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron. Journal of Biological Chemistry 280 2005 22 20978 20986
18. B Langley J M Gensert M F Beal Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. Current Drug Targets 4 2005 1 41 50
19. G A Soliman The mammalian target of rapamycin signalling network and gene regulation. Current Opinion in Lipidology 16 2005 3 317 323
20. H Ryu K Smith S I Camelo Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. Journal of Neurochemistry 93 2005 5 1087 1098